Akzo Nobel N V S/Adr
(AKZOY)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,255,665 | 1,160,613 | 1,637,520 | 1,815,451 | 1,633,419 |
| Marketable Securities | 3,231 | 31,485 | 286,810 | 255,774 | 256,244 |
| Receivables | 3,139,164 | 3,060,588 | 2,687,351 | 3,088,879 | 3,044,397 |
| Inventories | 1,977,188 | 1,931,460 | 1,784,713 | 1,868,783 | 1,915,833 |
| Other current assets | 148,612 | 145,485 | 145,028 | 170,879 | 166,831 |
| TOTAL | $6,523,860 | $6,329,631 | $6,541,421 | $7,199,766 | $7,016,724 |
| Non-Current Assets | |||||
| PPE Net | 2,172,107 | 2,180,086 | 2,158,106 | 2,141,971 | 2,132,823 |
| Intangibles | 4,368,983 | 4,453,542 | 4,416,866 | 4,517,948 | 4,404,125 |
| Other Non-Current Assets | 2,532,869 | 2,572,022 | 2,639,730 | 2,506,585 | 2,654,033 |
| TOTAL | $9,073,959 | $9,205,650 | $9,214,702 | $9,166,504 | $9,190,981 |
| Total Assets | $15,597,820 | $15,535,280 | $15,756,120 | $16,366,270 | $16,207,710 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,189,778 | 3,144,187 | 3,174,386 | 3,219,487 | 3,089,103 |
| Other current liabilities | 165,843 | 163,941 | 405,863 | 458,216 | 488,499 |
| TOTAL | $5,929,412 | $5,642,383 | $6,175,604 | $6,226,736 | $6,198,924 |
| Non-Current Liabilities | |||||
| Long Term Debt | 3,426,696 | 3,455,783 | 3,425,479 | 3,987,898 | 4,014,853 |
| Other Non-Current Liabilities | -16,154 | -14,114 | -7,503 | -8,707 | -16,356 |
| TOTAL | $4,596,209 | $4,671,767 | $4,660,384 | $5,117,657 | $5,191,395 |
| Total Liabilities | $10,525,620 | $10,314,150 | $10,835,990 | $11,344,390 | $11,390,320 |
| Shareholders' Equity | |||||
| Common Shares | 91,537 | 92,285 | 91,996 | 92,514 | 92,684 |
| Other shareholders' equity | 4,980,663 | 5,128,847 | 4,828,141 | 4,929,363 | 4,724,703 |
| TOTAL | $5,072,199 | $5,221,131 | $4,920,136 | $5,021,877 | $4,817,387 |
| Total Liabilities And Equity | $15,597,819 | $15,535,281 | $15,756,126 | $16,366,267 | $16,207,707 |